Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction?

Nephrology Dialysis Transplantation

Volumn 24, Issue 3, 2009, Pages 1009-1014

  Sánchez Villanueva, Rafael ^a   Bajo, Auxiliadora ^a   Del Peso, Gloria ^a   Fernandez Reyes, M Jose ^b   González, Elena ^a   Romero, Sara ^a   Estrada, Patricia ^a   Selgas, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Daily peritoneal protein clearance; Endothelial dysfunction; Peripheral arterial disease

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CLEARANCE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONEAL PROTEIN CLEARANCE; PRIORITY JOURNAL; PROTEIN DEPLETION; SURVIVAL RATE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PERITONEAL DIALYSIS; PERITONEUM; PROTEINS; RISK FACTORS;

EID: 60749117818     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn595     Document Type: Article

References (48)

1. Kopple JD, Blumenkrantz MJ, Jones MR et al. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982; 36: 395-402
2. Dombros N, Oren A, Marliss EB et al. Plasma amino acid profiles and amino acid losses in patients undergoing CADP. Perit Dial Int 1982; 2: 27-32
3. Blumenkrantz MJ, Gahl GM, Kopple JD et al. Protein losses during peritoneal dialysis. Kidney Int 1981; 19: 593-602
4. Gordon S, Rubini ME. Protein losses during peritoneal dialysis. Am J Med Sci 1967; 253: 283-292
5. Katirtzoglou A, Oreopoulos DG, Husdan H et al. Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 1980; 26: 230-233
6. Rubin J, McFarland S, Hellems EW et al. Peritoneal dialysis during peritonitis. Kidney Int 1981; 19: 460-464
7. Popovich RP, Moncrief JW, Nolph KD et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449-456
8. Rubin J, Ray R, Barnes T et al. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 1981; 29: 124-127
9. K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000; 35: S1-S140
10. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997; 336: 1014-1016
11. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
12. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997; 30: 923-927
13. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29: 658-668
14. Moshage HJ, Janssen JA, Franssen JH et al. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79: 1635-1641
15. Acchiardo SR, Moore LW, Latour PA. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 24: S199-S203
16. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
17. Avram MM, Goldwasser P, Erroa M et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 1994; 23: 91-98
18. Avram MM, Fein PA, Bonomini L et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five-year prospective study. Perit Dial Int 1996; 16(Suppl 1): S190-S194
19. Folsom AR, Ma J, Eckfeldt JH et al. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1995; 5: 186-191
20. Szeto CC, Chow KM, Lam CW et al. Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: a prospective cohort study. Perit Dial Int 2005; 25: 445-452
21. Heaf JG, Sarac S, Afzal S. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 2194-2201
22. Szeto CC, Chow KM, Chung KY et al. Peritoneal protein and albumin excretion as markers of cardiovascular risk factor and systemic endothelial dysfunction. Hong Kong J Nephrol 2004; 6: 31-37
23. US Renal Data System. USRDS. Atlas of end-stage renal disease in the United States. 2003 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003
24. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
25. de Vinuesa SG, Ortega M, Martinez P et al. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int Suppl 2005; S44-S47
26. Leskinen Y, Salenius JP, Lehtimaki T et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002; 40: 472-479
27. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2838-2847
28. O'Hare AM, Glidden DV, Fox CS et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109: 320-323
29. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386
30. Selgas R, Bajo MA, Cirugeda A et al. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25: 68-76
31. Beddhu S, Bruns FJ, Saul M et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108: 609-613
32. Selgas R, Fernandez-Reyes MJ, Bosque E et al. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23: 64-73
33. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341-356
34. Kabanda A, Goffin E, Bernard A et al. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48: 1946-1952
35. Cueto-Manzano AM, Gamba G, Correa-Rotter R. Quantification and characterization of protein loss in continuous ambulatory peritoneal dialysis. Rev Invest Clin 2000; 52: 611-617
36. Bohm M, Thoenes M, Danchin N et al. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. JHypertens 2007; 25: 2317-2324
37. Vupputuri S, Shoham DA, Hogan SL et al. Microalbuminuria, peripheral artery disease, and cognitive function. Kidney Int 2008; 73: 341-346
38. Kuo HK, Lin LY, Yu YH. Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002. J Intern Med 2007; 262: 562-570
39. Kopanati S, Baum M, Quan A. Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis. Pediatr Nephrol 2006; 21: 1013-1019
40. Vongpatanasin W. Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction. J Clin Hypertens (Greenwich) 2007; 9: 11-15
41. Liew YP, Bartholomew JR, Demirjian S et al. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol 2008; 3: 1084-1089
42. Liew YP, Bartholomew JR, Demirjian S et al. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol 2008; 3: 1084-1089
43. Menke A, Muntner P, Wildman RP et al. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226-1230
44. Wattanakit K, Folsom AR, Selvin E et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2005; 180: 389-397
45. Spaia S, Christidou F, Pangidis P et al. Variability of peritoneal protein loss in diabetic and nondiabetic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S242-S244
46. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007; 117: 2362-2368
47. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184
48. Shankar A, Klein BE, Nieto FJ et al. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 2008; 196: 749-755